Elite Pharmaceuticals, Inc. Deferred State and Local Income Tax Expense (Benefit)
Elite Pharmaceuticals, Inc. (ELTP) reported Deferred State and Local Income Tax Expense (Benefit) of $208.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-06-29
- Elite Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2026 was $208.00K.
- Elite Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2025 was -$76.00K.
- Elite Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2024 was -$281.00K.
- Elite Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2018 was $0.00.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2026-03-31 | $208.00K 10-K · filed 2026-06-29 |
| 2025-03-31 | -$76.00K 10-K · filed 2026-06-29 |
| 2024-03-31 | -$281.00K 10-K · filed 2025-06-30 |
| 2018-03-31 | $0.00 10-K · filed 2018-06-14 |
| 2017-03-31 | $0.00 10-K · filed 2018-06-14 |
| 2016-03-31 | $0.00 10-K · filed 2018-06-14 |
| 2015-03-31 | $0.00 10-K · filed 2017-06-14 |
| 2014-03-31 | $0.00 10-K · filed 2016-06-15 |
| 2013-03-31 | $0.00 10-K · filed 2014-06-30 |
| 2012-03-31 | $0.00 10-K · filed 2013-06-21 |